F10 and chronic kidney disease: It inhibits the coagulation process by binding to antithrombin, and then accelerates antithrombin’s inhibition of activated factor X. IP injection of LMWH is commonly used in a setting of peritonitis in end-stage renal disease patients undergoing CAPD, mostly to diminish fibrin deposition and to prevent the occlusion of the peritoneal catheter and intra-abdominal adhesions[10].